Form 13-F position report

AVADEL PHARMACEUTICALS PLC

Reported by WEXFORD CAPITAL LP

AVDL CUSIP G29687103 Manager CIK 0001048462

First reported at 272,821 shares this quarter.

New
% of reported 13F value 1.13% This manager · Q4 2025
Shares 272,821 Quarter-end amount reported
Reported value $5,879,290 Fair value at quarter end
Consecutive quarters held 1 Through Q4 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-03-31 722790
2025-06-30 0
2025-12-31 5879290
2026-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for AVADEL PHARMACEUTICALS PLC held by WEXFORD CAPITAL LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2026 Reduced 0 -272,821 (-100.0%) 0 $0 2026-05-15
Q4 2025 New 272,821 +272,821 (0.0%) 1.13% $5,879,290 2026-02-13
Q2 2025 Reduced 0 -92,310 (-100.0%) 0 $0 2025-08-14
Q1 2025 New 92,310 +92,310 (0.0%) 0.19% $722,790 2025-05-15

Who else reported the position

256 managers reported AVADEL PHARMACEUTICALS PLC for Q4 2025.

Managers reporting AVADEL PHARMACEUTICALS PLC in Q4 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 7,041,102 +67,444 < 0.01% $151,735,747 6 qtrs
VANGUARD GROUP INC Added 5,864,781 +258,499 < 0.01% $126,386,030 7 qtrs
GENDELL JEFFREY L Reduced 4,769,357 -545,453 1.79% $102,779,643 7 qtrs
Weiss Asset Management LP New 4,515,114 +4,515,114 1.28% $97,300,707 1 qtr
TIG Advisors LLC New 3,859,122 +3,859,122 3.85% $83,164,079 1 qtr
TUDOR INVESTMENT CORP ET AL Added 2,983,541 +2,939,779 0.12% $64,295,309 6 qtrs
FIL Ltd New 2,822,777 +2,822,777 0.05% $60,830,844 1 qtr
Vivo Capital LLC Unchanged 2,684,109 0 3.74% $57,842,549 6 qtrs
STATE STREET CORPORATION Reduced 2,278,301 -14,306 < 0.01% $49,097,387 7 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 2,156,356 -19,421 < 0.01% $46,477,231 7 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2025
Filed
February 13, 2026
Filing type
13F-HR
Position type
COM SHS

Voting authority reported

Sole
272,821
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.